Smoking boosts clopidogrel effect in people with diabetes and CAD

04/9/2012 | Medscape (free registration)

Data on 134 patients with type 2 diabetes and coronary artery disease who were on maintenance clopidogrel therapy showed that those who smoked were less likely to suffer from high on-treatment platelet reactivity than nonsmokers. However, researchers warned that cardiovascular events, including mortality, remained higher for smokers. The results were published in JACC: Cardiovascular Interventions.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR CLINICAL RESEARCH - 14000003MB
Abbott
Santa Clara, CA
Senior Officer, Drugs and Medical Devices
The Pew Charitable Trusts
Washington, DC
Director of ASO Department
Bluegrass Family Health
Lexington-or could be in Nashville, TN, KY
Mgr NGS Provider Enrollment (I)
National Government Services - WellPoint
Harrisburg, PA
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA